You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Sherley v. Sebelius

Citation: Not availableDocket: Civil Action No. 2009-1575

Court: District Court, District of Columbia; July 27, 2011; Federal District Court

Original Court Document: View Document

Narrative Opinion Summary

This judicial opinion revolves around a lawsuit filed by two scientists challenging the NIH Guidelines for Human Stem Cell Research, claiming that the guidelines violate the Dickey-Wicker Amendment and the Administrative Procedure Act (APA). Initially dismissed for lack of standing, the case was reinstated on appeal, with the Court of Appeals finding that the plaintiffs had standing due to increased competition for NIH funds. The primary legal issue centers on the interpretation of the Dickey-Wicker Amendment, which prohibits federal funding for research involving the destruction of human embryos. The Court ultimately deferred to the NIH's interpretation under the Chevron standard, allowing funding for research using embryonic stem cells, as it did not involve the destruction of embryos. The Court also addressed procedural compliance with the APA, ruling that the NIH was not required to consider public comments opposing funding for embryonic stem cell research, as the comments were beyond the scope of the Executive Order. The Court granted summary judgment in favor of the defendants, upholding the NIH guidelines and dismissing the plaintiffs' claims.

Legal Issues Addressed

Administrative Procedure Act Compliance

Application: The Court found that the NIH did not violate the APA when it chose not to address comments opposing embryonic stem cell research funding, as the comments were outside the scope of the guidelines mandated by the Executive Order.

Reasoning: The NIH was not required to solicit comments on whether to fund human embryonic stem cell research in its notice of proposed rulemaking because such comments were outside the scope of the guidelines mandated by President Obama’s Executive Order 13,505, which necessitated the establishment of funding guidelines for ethical and scientifically viable research.

Chevron Deference

Application: The NIH's interpretation of the Dickey-Wicker Amendment was granted deference under the Chevron standard, as the agency's interpretation was deemed a permissible construction of the statute.

Reasoning: Consequently, since the Dickey-Wicker Amendment does not clarify the ambiguity, the Court must proceed to Chevron step two, which requires deference to the NIH's interpretation if it represents a permissible construction of the statute.

Interpretation of the Dickey-Wicker Amendment

Application: The Court determined that the Amendment's language was ambiguous regarding whether it prohibits federal funding for research involving embryonic stem cells, ultimately deferring to the NIH's interpretation.

Reasoning: The Court of Appeals determined that the plaintiffs were unlikely to succeed on the merits, interpreting the Dickey-Wicker Amendment as ambiguous and upholding the NIH's conclusion that while the Amendment bars funding for the act of deriving embryonic stem cells, it does not prohibit funding for research projects utilizing those cells.

Standing in Federal Court

Application: The case was initially dismissed due to lack of standing, but on appeal, the Court of Appeals found that the plaintiffs had standing due to increased competition for NIH funds, constituting an actual injury.

Reasoning: The plaintiffs appealed, and the Court of Appeals for the District of Columbia reversed the decision, finding that both Drs. Sherley and Deisher had standing due to the actual injury caused by intensified competition for limited NIH funds.